Collegium Pharmaceutical, Inc. announced the appointment of Neil F. McFarlane to its Board of Directors, effective April 6, 2022. Neil F. McFarlane most recently served as the Chief Executive Officer and a member of the Board of Directors of Adamas Pharmaceuticals, Inc.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
32.15 USD | +2.06% | -13.16% | +4.45% |
May. 13 | Collegium Pharmaceutical Launches $35 Million Accelerated Share Repurchase Program | MT |
May. 10 | Needham Downgrades Collegium Pharmaceutical to Hold From Buy | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.45% | 1.05B | |
+29.98% | 682B | |
+31.20% | 586B | |
-3.52% | 364B | |
+18.59% | 327B | |
+4.07% | 285B | |
+17.00% | 240B | |
+9.97% | 209B | |
-8.22% | 203B | |
+7.09% | 165B |
- Stock Market
- Equities
- COLL Stock
- News Collegium Pharmaceutical, Inc.
- Collegium Pharmaceutical, Inc. Appoints Neil McFarlane to its Board of Directors